BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Female Sexual Dysfunction

Below is an extended Female Sexual Dysfunction patents listing. Click here to return to the Female Sexual Dysfunction main in depth entry.

Patents :

US Patent No.Title
7312223 Metabolite of xanthine Phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction
7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
7347815 Method and apparatus for converting sense-perceived thoughts and actions into physical sensory stimulation
7348339 Imidazopyridine derivatives as kinase inhibitors
7351698 Androgen receptor modulators and methods of use thereof
7351828 Benzimidazoles that are useful in treating sexual dysfunction
7354923 Piperazine melanocortin-specific compounds
7361661 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
7365095 Chromane and chromene derivatives and uses thereof
7368477 Benzofuranyl alkanamine derivatives and uses thereof
7368577 Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof
7332513 Thiazole-based nitric oxide donors having acyl substituent(s) and uses thereof
7329777 Methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis
7329673 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
7312330 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
7314871 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension
7314879 Melanocortin receptor agonists
7317016 Methods of treating medical conditions using sulfonate-substituted pyrazolopyridine derivatives
7320968 Pharmaceutical composition
7321074 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight
7323462 Morpholine dopamine agonists
7326707 Bicyclic melanocortin-specific compounds
7326732 EP2 receptor agonists
7328069 Method, system and device for treating disorders of the pelvic floor by electrical stimulation of and the delivery of drugs to the left and right pudendal nerves
7369894 Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves
7371415 Method and composition for improving sexual fitness
7405234 Bicyclic modulators of androgen receptor function
7405303 Substituted quinoline compounds for use as selective estrogen receptor modulator
7407949 Benzamide derivatives as oxytocin agonists and vasopressin antagonists
7410962 Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
7410973 4-amino-substituted pyrimidine derivatives
7414057 Piperazine urea derivatives as melanocortin-4 receptor agonists
7414131 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
7417013 Warming and nonirritating lubricant compositions and method of comparing irritation
7417027 Linear and cyclic melanocortin receptor-specific peptides
7417040 Fused tricyclic compounds as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3
7405186 Lubricant compositions, condom products and methods of making same
7402687 Dihydrobenzofuran derivatives and uses thereof
7402577 Androstane 17-beta-carboxamides as androgen receptor modulators
7378426 Fused heterotricyclic compounds as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3
7378436 Compounds
7381699 Reagents and methods for smooth muscle therapies
7384958 Quinoline inhibitors of cGMP phosphodiesterase
7385025 Metallopeptide compounds
7388027 Bicyclic compounds as modulators of androgen receptor function and method
7393825 Microdose therapy
7396814 Metallopeptide compositions for treatment of sexual dysfunction
7396829 Nitric oxide enhancing diuretic compounds, compositions and methods of use
7396857 Therapeutic combinations for the treatment or prevention of depression
7417068 EP.sub.4 receptor antagonists
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional